Facebook’s independent Oversight Board has ruled against the social media giant’s decision to remove an October 2020 post touting hydroxychloroquine (HCQ) – the antimalarial which Democrats and their media surrogates were cautiously optimistic about until former President Trump promoted it.
“In October 2020, a user posted a video and accompanying text in French in a public Facebook group related to COVID-19,” explained the board on its website. “The post alleged a scandal at the Agence Nationale de Sécurité du Médicament (the French agency responsible for regulating health products), which refused to authorize hydroxychloroquine combined with azithromycin for use against COVID-19, but authorized and promoted remdesivir. The user criticized the lack of a health strategy in France and stated that “[Didier] Raoult’s cure” is being used elsewhere to save lives. The user’s post also questioned what society had to lose by allowing doctors to prescribe in an emergency a “harmless drug” when the first symptoms of COVID-19 appear.”
The Oversight Board noted that the user’s post did not encourage people to take HCQ without a prescription, and was instead “opposing a governmental policy and aimed to change that policy.”
“The combination of medicines that the post claims constitute a cure are not available without a prescription in France and the content does not encourage people to buy or take drugs without a prescription. Considering these and other contextual factors, the Board noted that Facebook had not demonstrated the post would rise to the level of imminent harm, as required by its own rule in the Community Standards,” the Board continued, adding that Facebook failed to satisfactorily explain why it removed the post, and that their ‘misinformation and imminent harm rule’ is too vague – recommending that the company clarify its standards on health misinformation.
“The Board also found Facebook’s misinformation and imminent harm rule, which this post is said to have violated, to be inappropriately vague and inconsistent with international human rights standards,” wrote the panel. “A patchwork of policies found on different parts of Facebook’s website make it difficult for users to understand what content is prohibited. Changes to Facebook’s COVID-19 policies announced in the company’s Newsroom have not always been reflected in its Community Standards, while some of these changes even appear to contradict them.”
One can’t help but wonder how many lives the left’s politicization of HCQ may have cost, after several studies have concluded that when taken early into a COVID-19 infection, the antimalarial has been shown to reduce mortality.
The currently completed retrospective studies and randomized trials have generally shown these findings: 1) when started late in the hospital course and for short durations of time, antimalarials appear to be ineffective, 2) when started earlier in the hospital course, for progressively longer durations and in outpatients, antimalarials may reduce the progression of disease, prevent hospitalization, and are associated with reduced mortality. –American Journal of Medicine
A meta-analysis of 105,040 cases from 20 studies in 9 countries found a reduction in mortality by up to three times in groups treated early with Hydroxychloroquine and Azithromycin.
Unfortunately for those hoping to use HCQ, Trump made the mistake of endorsing it, setting off a cascade of anti-HCQ propaganda which has been largely disproven.
We’re beginning to like this Oversight Board.
Republished from ZeroHedge.com with permission
The post Facebook Oversight Reverses Hydroxychloroquine Censorship Decision appeared first on We Are Change.
Read MoreWe Are Change
31 total views, 1 views today